Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression

Completed · Not applicable

Conditions studied: Treatment Resistant Depression, Major Depressive Disorder, Severe Depression

In brief

In this proof of concept study, the investigators plan to administer iv ketamine interleaved with ECT days. Patients with treatment resistant depression who are deemed to be eligible for ECT treatment will randomly be assigned to either ketamine or active placebo.

Key facts

Study ID
NCT02522377
Run by
The Cleveland Clinic
People needed
15
Starts
2015-08-01
Expected to finish
2018-03-01
Last updated by the study team
2019-08-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.